Latest News


Crystec’s Chief Scientist contributes to the publication of distinguished work by SIMM, from Shanghai Synchrotron studies, which provides new insights into  the development of inhaled medicines - Thumbnail Image
Crystec launch a new R&D centre in Haimen, Jiangsu province, China - Thumbnail Image

Crystec launch a new R&D centre in Haimen, Jiangsu province, China

HAIMEN, CHINA: 31st March, 2021

Crystec shortlisted for 2020 CPhI Excellence in Pharma Awards: Innovation in Response to COVID-19 - Thumbnail Image

Crystec shortlisted for 2020 CPhI Excellence in Pharma Awards: Innovation in Response to COVID-19

Crystec are delighted to have been selected as a finalist for the 2020 CPhI Excellence in Pharma Awards in the category of Innovation in Response to COVID-19.

CrystecPharma receive patent approval in the  European Union and China - Thumbnail Image

CrystecPharma receive patent approval in the European Union and China

CrystecPharma are pleased to announce the approval of patent applications for their lead asset, CR002. Applications with China’s National Intellectual Property Administration (CNIPA) and the European Patent Office (EPO) have recently been approved. National filings are ongoing in other key territories.